
TESA 60mg Pack
Save 20% & Get a Free Pen
$356.00$264.00
Experience top quality with the TESA Synergistic Peptide 60mg Pack. Each set includes three vials (20mg each) of highly pure peptides (99% purity) for your research needs. Act now to receive a complimentary V2 Pen with a cartridge for easy administration, making this offer practical and valuable. Normally priced at $355, get this bundle for only $264!
Tesamorelin Peptide
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It is commonly studied for its ability to stimulate endogenous growth hormone signaling pathways and influence metabolic processes associated with body composition.
Researchers and investigators have explored Tesamorelin in controlled settings to better understand its potential effects on growth hormone dynamics, lipid metabolism, and physiological regulation associated with aging and metabolic function.
Mechanism of Action (Research Context)
Tesamorelin is designed to interact with growth hormone-releasing hormone receptors located in the pituitary gland. Activation of these receptors may stimulate the natural pulsatile release of growth hormone, which can subsequently influence insulin-like growth factor-1 (IGF-1) signaling pathways.
Growth hormone pathways are associated with:
Lipid metabolism regulation
Protein synthesis signaling
Cellular repair mechanisms
Hormonal communication pathways
Tissue regeneration processes
Areas of Scientific Interest
Current scientific literature has explored Tesamorelin in relation to:
Body composition regulation
Growth hormone and IGF-1 signaling pathways
Metabolic function research
Visceral adipose tissue physiology
Sleep and recovery-related hormone activity
Cellular aging pathways
These areas remain subjects of ongoing investigation.
Research Observations Reported in Literature
Investigational studies involving growth hormone–releasing peptides have reported associations with:
Changes in growth hormone biomarkers
Alterations in metabolic signaling markers
Modulation of lipid metabolism pathways
Physiological processes related to tissue maintenance
Hormonal feedback loop responses
Results vary depending on study design, dosing models, and research populations.
Distinguishing Characteristics
Compared with some other growth hormone–related peptides, Tesamorelin has been studied for:
High receptor specificity for GHRH pathways
Consistent stimulation of endogenous hormone signaling
Predictable pharmacokinetic profile in research settings
Important Research Notice
This product is intended for laboratory research purposes only.
Not for human consumption
Not for medical use
Not intended to diagnose, treat, cure, or prevent any disease
Use only by qualified professionals in controlled research environments
Products offered by Peptidea are supplied strictly for scientific and educational research applications.
Quality Commitment
At Peptidea, we are committed to supporting the research community by providing:
High-purity research materials
Transparent documentation standards
Batch identification and traceability
Educational resources to support responsible research
Disclaimer
All information provided is for educational and informational purposes only and reflects published scientific literature and investigational research. Statements have not been evaluated by the Food and Drug Administration.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.
